Crucially, we introduce a novel mechanism wherein FGF7 serves as a critical regulatory factor facilitating crosstalk between CAFs and cancer cells, thereby promoting the progression of OC via activation of the HIF1α/EMT signaling axis. The gene discussed is HIF1A; the disease is cancer.